These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 30939271)
1. Role of Magnetic Resonance Imaging in Diagnosis of Motor Neuron Disease: Literature Review and Two Case Illustrations. Sawalha K; Gonzalez-Toledo E; Hussein O Perm J; 2019; 23():. PubMed ID: 30939271 [TBL] [Abstract][Full Text] [Related]
2. Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates. Vinceti G; Olney N; Mandelli ML; Spina S; Hubbard HI; Santos-Santos MA; Watson C; Miller ZA; Lomen-Hoerth C; Nichelli P; Miller BL; Grinberg LT; Seeley WW; Gorno-Tempini ML Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):146-158. PubMed ID: 30668155 [No Abstract] [Full Text] [Related]
3. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease. van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409 [TBL] [Abstract][Full Text] [Related]
4. Structural MRI Signatures in Genetic Presentations of the Frontotemporal Dementia/Motor Neuron Disease Spectrum. Spinelli EG; Ghirelli A; Basaia S; Cividini C; Riva N; Canu E; Castelnovo V; Domi T; Magnani G; Caso F; Caroppo P; Prioni S; Rossi G; Tremolizzo L; Appollonio I; Silani V; Carrera P; Filippi M; Agosta F Neurology; 2021 Oct; 97(16):e1594-e1607. PubMed ID: 34544819 [TBL] [Abstract][Full Text] [Related]
5. EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Filippi M; Agosta F; Abrahams S; Fazekas F; Grosskreutz J; Kalra S; Kassubek J; Silani V; Turner MR; Masdeu JC; Eur J Neurol; 2010 Apr; 17(4):526-e20. PubMed ID: 20136647 [TBL] [Abstract][Full Text] [Related]
6. Promises and pitfalls of imaging-based biomarkers in motor neuron diseases. Tan EL; Bede P; Pradat PF Curr Opin Neurol; 2023 Aug; 36(4):346-352. PubMed ID: 37382064 [TBL] [Abstract][Full Text] [Related]
7. Neurometabolic Alterations in Motor Neuron Disease: Insights from Magnetic Resonance Spectroscopy. Christidi F; Karavasilis E; Argyropoulos GD; Velonakis G; Zouvelou V; Murad A; Evdokimidis I; Rentzos M; Seimenis I; Bede P J Integr Neurosci; 2022 Apr; 21(3):87. PubMed ID: 35633168 [TBL] [Abstract][Full Text] [Related]
8. Brain MR Imaging in Patients with Lower Motor Neuron-Predominant Disease. Spinelli EG; Agosta F; Ferraro PM; Riva N; Lunetta C; Falzone YM; Comi G; Falini A; Filippi M Radiology; 2016 Aug; 280(2):545-56. PubMed ID: 26963576 [TBL] [Abstract][Full Text] [Related]
9. Structural and functional brain signatures of C9orf72 in motor neuron disease. Agosta F; Ferraro PM; Riva N; Spinelli EG; Domi T; Carrera P; Copetti M; Falzone Y; Ferrari M; Lunetta C; Comi G; Falini A; Quattrini A; Filippi M Neurobiol Aging; 2017 Sep; 57():206-219. PubMed ID: 28666709 [TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron. Chan S; Kaufmann P; Shungu DC; Mitsumoto H Neuroimaging Clin N Am; 2003 May; 13(2):307-26. PubMed ID: 13677809 [TBL] [Abstract][Full Text] [Related]
11. The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools. Bede P; Querin G; Pradat PF Curr Opin Neurol; 2018 Aug; 31(4):431-438. PubMed ID: 29750730 [TBL] [Abstract][Full Text] [Related]
12. Multimodal structural MRI in the diagnosis of motor neuron diseases. Ferraro PM; Agosta F; Riva N; Copetti M; Spinelli EG; Falzone Y; Sorarù G; Comi G; Chiò A; Filippi M Neuroimage Clin; 2017; 16():240-247. PubMed ID: 28794983 [TBL] [Abstract][Full Text] [Related]
13. Advances in the neuroimaging of motor disorders. Weil EL; Nakawah MO; Masdeu JC Handb Clin Neurol; 2023; 195():359-381. PubMed ID: 37562878 [TBL] [Abstract][Full Text] [Related]
14. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease. Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320 [TBL] [Abstract][Full Text] [Related]
15. The clinical and radiological profile of primary lateral sclerosis: a population-based study. Finegan E; Chipika RH; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; McLaughlin RL; Pender N; Hardiman O; Bede P J Neurol; 2019 Nov; 266(11):2718-2733. PubMed ID: 31325016 [TBL] [Abstract][Full Text] [Related]
16. Teaching NeuroImages: Mills syndrome: Metabolic and structural neuroimaging aids to the diagnostic. Porto FH; Coutinho AM; Lucato LT; Buchpiguel CA; Nitrini R Neurology; 2016 Aug; 87(5):e54. PubMed ID: 27481464 [No Abstract] [Full Text] [Related]
17. Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routine. Rocha AJ; Maia Júnior AC Arq Neuropsiquiatr; 2012 Jul; 70(7):532-9. PubMed ID: 22836461 [TBL] [Abstract][Full Text] [Related]
18. Propagation patterns in motor neuron diseases: Individual and phenotype-associated disease-burden trajectories across the UMN-LMN spectrum of MNDs. Tahedl M; Li Hi Shing S; Finegan E; Chipika RH; Lope J; Hardiman O; Bede P Neurobiol Aging; 2022 Jan; 109():78-87. PubMed ID: 34656922 [TBL] [Abstract][Full Text] [Related]